Thrombosis of the cavernous sinus following prone-position spinal surgery in a patient with factor V Leiden;Trombosis de seno cavernoso tras una cirugĺa raquldea en decúbito prono en un paciente portador del factor V de Leiden

Revista de Neurologia

Volumn 48, Issue 6, 2009, Pages 297-300

  Casado Menendez I ^a   Gonzalez Rodriguez C ^a   Diaz Gonzalez M ^a   Díaz Castroverde, A Gómez ^a   Fayad, M ^a   De La Cruz, R ^a  

^a HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Cavernous sinus; Factor V leiden; Hypercoagulability; Prone position; Surgery; Vein thrombosis

Indexed keywords

ACETAZOLAMIDE; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TIMOLOL; BLOOD CLOTTING FACTOR 5;

ABSENCE OF SIDE EFFECTS; ADULT; ANGIOGRAPHY; ARTICLE; BLINDNESS; CARDIOVASCULAR RISK; CASE REPORT; CAVERNOUS SINUS THROMBOSIS; ECCHYMOSIS; EXOPHTHALMOS; EYE PAIN; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; MALE; SPINE SURGERY; VISUAL ACUITY; ANATOMY AND HISTOLOGY; BODY POSTURE; CAVERNOUS SINUS; GENETICS; HETEROZYGOTE; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; RISK FACTOR; SPINE; SURGERY; THROMBOSIS;

CAVERNOUS SINUS; FACTOR V; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PRONE POSITION; RISK FACTORS; SPINE; THROMBOSIS;

EID: 65249134377     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4806.2008606     Document Type: Article

References (25)

1. Milandre L, Gueriot C, Girard N. Les thromboses veineuses cérébrales de l'adulte. Ann Med Intern 1988; 139: 544-7.
2. Rohana AR, Rosli MK, Nik Rizal NY, Shatriah I, Wan Hazabbah WH. Bilateral ophthalmic vein thrombosis secondary to nasal furunculosis. Orbit 2008; 27: 215-7.
3. Goawalla A, Mansell N, Pearson A. Septic cavernous sinus thrombosis with bilateral secondary orbital infection. Orbit 2007; 26: 113-6.
4. Nadkarni TD, Dindorkar KS, Desai K, Goel A. Cavernous sinus thrombosis and air embolism following surgery for acoustic neurinoma: a case report. Neurol India 2002; 50: 201-3.
5. Anand S, Mushin AS. Cavernous sinus thrombosis following prone position anaesthesia. Eye 2005; 19: 803-4.
6. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90: 1004-8.
7. Bertina RM, Koeleman BPMC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
8. Ludemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, etal. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis. A case-control study of 55 patients. Stroke 1998; 29: 2507-10.
9. Medrano V, Mallada-Frechín J, Fernández-Izquierdo S, Piqueras-Ro-dríguez L. Trombosis venosa cerebral y factor V de Leiden. Rev Neurol 2006; 43: 49-50.
10. González-Hernández A, Fabre-Pi O, López- Fernández JC, Araña-Tole-do V, López-Veloso C, Suárez-Muñoz J. Prevalencia de los trastornos de la coagulación en una serie de trombosis de senos venosos cerebrales. Rev Neurol 2007; 45: 661-4.
11. Hollenhurst RW, Svien HJ, Benoit CF. Unilateral blindness occurring during anesthesia for neuro-surgical operations. Arch Ophthalmol 1954; 52: 819-30.
12. Patil CG, Lad EM, Lad SP, Ho C, Boakye M. Visual loss after spine surgery, a population-based study. Spine 2008; 33: 1491-6.
13. Gimeno MJ, Pina-Leita JI, Lasierra-Díaz R, Castillo-Lario MC, Carro-Alonso B. Diagnóstico mediante angiorresonancia y resonancia mag-nética por difusión de la trombosis del seno longitudinal superior. Rev Neurol 2006; 43: 121-3.
14. Bernal-Rodríguez R, Simón de las Heras R, Mateos-Beato F, Muñoz-González A. Trombosis venosa intracraneal: a propósito de 11 casos pe-diatricos. Rev Neurol 2008; 46: 273-9.
15. Lindhoff-Last E, Luxembourg B. Evidence-based indications for throm-bophilia screening. Vasa 2008; 37: 19-30.
16. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
17. Martinelli I, Landi G, Merati G, Cella R, Tossetto A, Mannucci PM. Factor V gen mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 1996; 75: 393-4.
18. Weih M, Vetter B, Ziemer S, Mehraein S, Valdueza JM, Koscielny J, et al. Increased rate of Factor V Leiden mutation in patients with cerebral vein thrombosis. J Neurol 1998; 245: 149-52.
19. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107: 2766-73.
20. Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108: 1129-34.
21. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementería F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International study on Cerebral Vein and Dural Thrombosis (ISCVT). Stroke 2004; 35: 664-70.
22. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pell-kofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
23. De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-8.
24. Canhão P, Cortesão A, Cabral M, Ferro JM, Stam J, Bousser MG, et al, ISCVT Investigators. Are steroids useful to treat cerebral venous thrombosis? Stroke 2008; 39:105-10.
25. Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004; CD003693.